EGFR and tongue cancer: The research suggested that lidocaine with 0.4mM concentration could inhibit the EGFR by combining with EGF to generate phosphorylation and lower proliferation of corneal epithelial cells (99), as well as inhibit the growth of CAL27 (tongue cancer cell line) by decreasing EGFR phosphorylation (100).